204 related articles for article (PubMed ID: 4134071)
1. [Multiple sclerosis and immunity].
Kroda Y; Kawanami S; Kuroiwa Y
Nihon Rinsho; 1973 Dec; 31(12):3381-6. PubMed ID: 4134071
[No Abstract] [Full Text] [Related]
2. Oligodendrocytes: the putative target cells of multiple sclerosis.
Abramsky O
Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
[No Abstract] [Full Text] [Related]
3. [Autoimmunity and nervous diseases].
Lehoczky T
Munch Med Wochenschr; 1966 Aug; 108(31):1518-22 passim. PubMed ID: 4169913
[No Abstract] [Full Text] [Related]
4. [Demyelination and autoimmunity].
Lebar R
Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694
[TBL] [Abstract][Full Text] [Related]
5. Auto-immunity and the central nervous system.
Levin JM; Boshes LD
Dis Nerv Syst; 1969 Apr; 30(4):273-9. PubMed ID: 4389144
[No Abstract] [Full Text] [Related]
6. Autoimmune aspects of demyelinating diseases.
Swanborg RH
Immunol Ser; 1990; 52():155-67. PubMed ID: 2091778
[No Abstract] [Full Text] [Related]
7. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.
Hafler DA
J Clin Invest; 1999 Sep; 104(5):527-9. PubMed ID: 10487765
[No Abstract] [Full Text] [Related]
8. [Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis].
Halpern B; Bakouche P; Martial-Lasfargues C
Presse Med (1893); 1969 Dec; 77(55):2103-6. PubMed ID: 4190510
[No Abstract] [Full Text] [Related]
9. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
Raine CS
Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
[No Abstract] [Full Text] [Related]
10. Pathogenetic aspects of multiple sclerosis and experimental models of inflammatory demyelination.
Wisniewski HM; Schuller-Levis GB; Mehta PD; Madrid RE; Lassmann H
Concepts Immunopathol; 1985; 2():128-50. PubMed ID: 2439203
[No Abstract] [Full Text] [Related]
11. [Multiple sclerosis: advances in its pathogenesis].
Godoy J; Court J
Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
[No Abstract] [Full Text] [Related]
12. [Etiopathogenesis of multiple sclerosis in the light of current studies].
Strelau K
Neurol Neurochir Pol; 1972; 6(1):93-8. PubMed ID: 4553032
[No Abstract] [Full Text] [Related]
13. [Virus as the cause of disseminated sclerosis?].
Høllsberg P; Haahr S
Ugeskr Laeger; 1986 Sep; 148(38):2390-3. PubMed ID: 3765165
[No Abstract] [Full Text] [Related]
14. Binding of encephalitogenic basic protein by serum alpha-globulins.
McPherson TA; Marchalonis JJ; Lennon V
Immunology; 1970 Dec; 19(6):929-33. PubMed ID: 4098879
[TBL] [Abstract][Full Text] [Related]
15. [Perivenous encephalomyelitis and multiple sclerosis].
Werner W
Med Klin; 1969 Oct; 64(42):1924-7. PubMed ID: 5357972
[No Abstract] [Full Text] [Related]
16. [The nature of the demyelinating process in clinical and experimental neurology].
Markov DA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
[No Abstract] [Full Text] [Related]
17. Editorial: Immunologic mysteries of multiple sclerosis.
Waksman BH
N Engl J Med; 1974 Jul; 291(1):45-6. PubMed ID: 4832403
[No Abstract] [Full Text] [Related]
18. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
Paterson PY; Day ED
Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
[No Abstract] [Full Text] [Related]
19. Immunological studies in experimental allergic encephalomyelitis and in multiple sclerosis with special reference to pathogenesis and diagnosis.
Lamoureux G
Proc Aust Assoc Neurol; 1966; 4():125-32. PubMed ID: 4165114
[No Abstract] [Full Text] [Related]
20. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
Lublin FD
Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):182-7. PubMed ID: 1377972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
